Episodic care costs can quickly rise when patients seek care at out-of-network facilities. Access to real-time information can help providers better monitor patients belonging to a bundle: https://t.co/ABT9CheeIP #BPCIAdvanced
The FDA BAP does not identify the reference product exclusivity issues the FDA intends to address or the position it may take, but much of the discussion surrounding RP exclusivity has focused on the “first-licensure” provision of the BPCIA: https://t.co/1W43VsScmx
Can I get an #APM? CMS has introduced only one new APM under this Administration (BPCI-A) and has yet to implement any of PTAC's recommendations for new APMs #2019MedPolicy https://t.co/EznvSh7pjR
